reason report
bottom line reiter op rate pt
quarter larg line vision strategi execut remain
differenti though posit catalyst seem fewer near term
take look less like polici uncertainti
least present headlin fundament risk report
larg line view modest beat rais rel sell side
consensu posit ep exchang
tax rate though off-set sg miss track record contract win
remain strong close vision ceo invest
system technolog lead cloud base captiv pbm innov
contract provid includ nc medicaid ascens medicar
advantag expans success roll region
plan hnt fide noteworthi competit advantag
make compel long term invest flip side posit
catalyst may limit margin expans like
till nc contract award limit tx contract award may
present binari risk organ top line growth may slow
exchang take near term well seem less like
view extens ceo employ agreement year
agre ceo view tx lawsuit decis
overturn play favor least scotu polici
uncertainti dimens impact earn rais
beyond estim modestli back rais
pt contempl price-to-earnings averag
ep
in-lin modest beat ep tax rate off-set
beat sell side estim tax rate off-set
miss exchang marketplac work favor
mix drive improv revenu also beat modestli cfo
ni exhibit
modest top bottom line rais rais mid
point non split adjust basi guidanc modestli improv
bp revenu guidanc also increas modestli tax rate
worsen modestli rais estim beyond
solid track record contract win though nc jv result
limit award boast success rate bid though
limit provid jv award disappoint compar peer
compani plan protest award exhibit
fide accret high singl digit percentag accret mm
synergi year low mid teen accret year
mm synergi remain track exhibit
compani inform svb leerink llc research
revenu billion adj ep pre-split basi ep adjust stock split
net debt total capit
price-to-earnings lt ep growth
average ep
gener long term ep growth period
year price history/av daili volume mil
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
ceo vision compani strategi execut remain
differenti track record contract win remain strong
close vision ceo invest system technolog
lead cloud base captiv pbm innov contract provid
includ nc medicaid ascens medicar advantag
expans success roll region plan hnt
fide noteworthi competit advantag make compel
howev near term posit catalyst fewer stock close
solid open like investor see fewer catalyst
near term less potenti take given extens ceo
employ agreement till agre ceo view
tx lawsuit decis overturn play favor
least scotu polici uncertainti dimens impact
pt contempl price-to-earnings averag
ep april report may tx award
reprocur june day catalyst exhibit
reiter op rate pt quarter larg line vision strategi
execut remain differenti though posit catalyst seem fewer near
term take look less like polici uncertainti least present
headlin fundament risk report larg in-lin view modest
beat rais rel sell side consensu posit ep exchang
tax rate though off-set sg miss track record contract win remain strong
close vision ceo invest system technolog lead cloud base
captiv pbm innov contract provid includ nc medicaid ascens medicar
advantag expans success roll region plan hnt
fide noteworthi competit advantag make compel long-term invest
flip side posit catalyst may limit margin expans like till
nc contract award limit tx contract award may present binari risk
organ top line growth may slow exchang take near term well
seem less like view extens ceo employ agreement year
agre ceo view tx lawsuit decis overturn play
favor least scotu polici uncertainti dimens impact
earn rais beyond estim modestli back rais
pt contempl price-to-earnings averag ep
modest beat ep tax rate off-set beat sell side
estim tax rate off-set miss exchang marketplac work
favor mix drive improv revenu also beat modestli cfo ni
tax rate bp off-set sg miss bp
consolid bp sg miss bp tax rate bp
corpearningsreport leerink estimatesstreet account consensusreport sequentialreport yoypremium servic revenu revenu ep share interest expens invest incom estim corpmetricsreport leerink estimatesstreet account consensusreport sequentialreport yoykey metricsconsolid bpsservic revenu bpsadj bpstax claim cfo/net corpor
dcp declin day sequenti day improv day yoy due fide acquisit
yoy membership growth driven fide acquisit
modest top bottom line rais rais midpoint non-split
adjust basi guidanc modestli improv bp revenu guidanc also
increas modestli tax rate worsen modestli rais estim
compani rais ep guidanc midpoint
dec feb leerink estimatesconsensu estimatestot revenu expens ratio excl acquisit relat tax share outstand corpor
modestli rais ep estim
solid track record contract win though nc jv result limit award
boast success rate bid though limit provid jv award
disappoint compar peer compani plan protest award link
note nc medicaid contract award
solid track record contract win re-procur contract
texa rfp reissu due mid-novemb
implement juli leader revenu
revenu link tx rfp note
consensussvb leerinkconsensussvb leerinkconsensussvb leerinkrevenu incom non-gaap growth medicaid success re-procur contract arizona florida washington kansa two new medicaid contract new mexico iowa overal win rate medicaid rfp remain industry-lead also medic manag effort network initi continu gain traction help drive improv hbr previous note addit strong organ growth engag strateg invest throughout year michael neidorff chairman ceo centen corp call corpor
tx rfp contract award due
fide accret high singl digit percentag accret mm synergi year
low mid-teen accret year mm synergi remain track
membership market shareestim revenu pmpm estim exposureright look like -- know rfp reissu due mid-novemb expect award go come right project start date plu chip rfp schwanek evp cfo centen centen corpor
fide synergi accret remain track
ceo vision compani strategi execut remain differenti track record
contract win remain strong close vision ceo invest system
technolog lead cloud base captiv pbm innov contract provid includ nc
medicaid ascens medicar advantag expans success roll
region plan hnt fide noteworthi competit advantag make
howev near term posit catalyst fewer stock close solid open like
investor see fewer catalyst near term less potenti takeout given extens
ceo employ agreement till agre ceo view tx lawsuit
decis overturn play favor least scotu polici uncertainti
dimens impact earn
remain track achiev accret synergi target anticip high single-digit percentageaccret adjust ep first month follow close low-to-mid-teen percentag accret adjust ep second full year follow close also anticip gener approxim million pre-tax net synergi first month follow close million total pre-tax netsynergi year two michael neidorff chairman ceo centen corp callthrough first six month fide perform line expect includ realiz anticip synergi integr continu go well expect achiev previous commun synergi target first second year post-acquisit jeffrey schwanek cfo treasur execut vice-president call corpor
ceo view tx lawsuit decis overturn play favor least scotu
balanc sheet healthi across leverag cfo balanc sheet solid
debt cap ratio cfo adj ni dcp pois
normal
debt capit end
first let provid commentari health care legisl legal regulatori environ hope divid govern lead greater construct dialogu parti come health carepolici clear medicaid servic provid need ever clearli numer governorsfrom parti strongli support medicaid manag care repeal-and-replac debat also haveseen utah nebraska idaho bilater initi recent pass medicaid expans also appear fromth recent marketplac enrol figur continu consist demand afford highqual health care coverag michael neidorff chairman ceo centen corp debt capit centen corpor
ratio remain solid
pt contempl price-to-earnings averag ep april
report may tx award reprocur june day catalyst
trade price-to-earnings consensu ep
note rel
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
pt contempl price-to-earnings averag ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base absolut price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
price target base price-to-earnings averag ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
integr regulatori risk across merg ci esrx
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price target base case
averag ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
pt contempl price-to-earnings consensu ep
price-to-earnings ep expect synergi across administr effici retail
steerag aet member benefit design chang floor rebat reduct
store base distribut part polici drive upsid estim also multipl
expans pt
underwrit risk aet asset trade peak margin commerci fulli
insur though medacorp commerci broker price survey give us confid
price environ remain appropri hard offer flat even potenti
modestli expand underwrit margin risk potenti futur margin compress
aet health insur even meaning given associ neg impact
debt ebitda load compani need focus debt
pay next month departur shawn guertin aet cfo
slate becom cfo make us less confid price postur
health insur book commenc new bulk compet
share gain commerci medicar advantag market
macroeconom risk risk macroeconom downturn higher
defens pbm sub sector given cyclic correl retail front store
sale employ data
regulatori risk convinc pbm add valu earn
low probabl threat potenti drug manufactur rebat elimin off-set
new busi model includ administr fee and/or perform guarante
expos pbm retail pharmaci busi compar
player pbm risk
execut integr risk face greater risk well given integr
pbm broader organ also transform agenda around
build retail front model amid risk leverag balanc sheet
e-commerce/amzn greater exposur eros sale on-line
channel well given exposur retail front store retail pharmaci e-
commerc though larg price retail multipl expect less like
pursu agenda becom pbm given associ integr clinic evid
base treatment guidelin integr provid network domin captiv pbm
model mega deal
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
averag ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
